NATIONAL HEALTHCARE CORP

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $50.5m $56.2m $59.0m $68.2m $41.9m $138.6m $22.4m $66.8m $101.9m $120.0m
Net Income (Loss) Available to Common Stockholders, Basic $50.5m $56.2m $59.0m $68.0m $42.0m $139.1m $20.0m $65.3m $102.1m $122.6m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $55.7m $58.7m $68.0m $42.0m $139.1m $20.0m $65.3m $102.1m $122.6m
Net Income (Loss) Attributable to Noncontrolling Interest ($523k) ($265k) ($235k) $119k $497k ($2.5m) ($1.5m) $159k $2.6m
Depreciation, Depletion and Amortization $39.0m $42.7m $41.9m $42.4m $42.0m $40.7m $40.5m $42.0m $42.0m $44.9m
Deferred Income Tax Expense (Benefit) $5.0m ($4.7m) $990k $5.6m ($11.0m) ($5.3m) $6.3m $5.8m $17.9m $7.2m
Share-based Payment Arrangement, Noncash Expense $509k $1.7m $1.8m $1.9m $2.5m $2.6m $2.6m $2.8m $4.2m $4.4m
Share-based Payment Arrangement, Expense $509k $1.7m $1.8m $1.9m $2.5m
Goodwill and Intangible Asset Impairment $0 $0 $0 $0 $0
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property $1.7m $0 $2.8m $0 $0 $6.2m $0 $0
Gain (Loss) on Disposition of Property Plant Equipment ($2.8m) $0 $0 ($6.2m) $0 $3.6m
Income (Loss) from Equity Method Investments $6.6m $6.9m $1.0m $9.7m $12.3m $5.1m $477k $2.0m $589k $218k
Income Tax Expense (Benefit) $29.7m $18.9m $16.2m $20.0m $10.4m $11.0m $7.3m $23.4m $34.3m $39.8m
Interest Expense Nonoperating $6.4m
Operating Lease, Expense $40.8m $41.0m $41.5m $43.2m $46.2m
Operating Lease, Lease Income $22.8m $22.7m $23.5m $23.9m $24.0m $25.0m
Other Nonoperating Income (Expense) $17.7m $26.7m $28.2m $17.8m $11.1m $16.7m $19.7m $18.1m
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable $4.4m $9.5m $9.4m ($4.3m) ($4.5m) ($4.1m) $3.9m $8.6m $26.4m $3.7m
Increase (Decrease) in Inventories ($60k) ($355k) $317k ($29k) $1.2m ($199k) ($1.5m) $298k $599k ($1.2m)
Debt Securities, Available-for-sale, Realized Gain (Loss) $18k $127k $195k $1.0m ($1.3m) ($667k) $1.1m $1.2m
Debt Securities, Realized Gain (Loss) $1.0m ($1.3m) ($667k) $1.1m $1.2m
Equity Securities, FV-NI, Unrealized Gain (Loss) $0 $1.1m $12.2m ($24.0m) ($13.9m) ($15.8m) $14.9m $31.0m $22.3m
General and Administrative Expense $29.3m $30.7m $24.8m $32.0m $20.2m $20.7m $21.4m $26.2m $27.5t
Goodwill $17.6m $17.6m $21.0m $21.0m $21.3m $168.3m $168.3m $168.3m $170.5m $170.5m
Insurance Services Revenue $7.1m $6.2m $5.4m $5.0m $4.8m $3.9m $3.3m $3.4m
Realized Investment Gains (Losses) $816k $262k $18k $127k $195k
Revenue from Contract with Customer, Including Assessed Tax $932.8m $947.9m $931.8m $965.5m $1.0b $1.1b $1.3b $1.5b
Net Cash Provided by (Used in) Operating Activities $90.9m $94.5m $98.4m $100.1m $203.3m $62.4m $8.7m $111.2m $107.3m $185.1m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $62.6m $32.3m $29.8m $26.4m $21.9m $39.4m $30.2m $27.9m $27.6m $36.4m
Net Cash Provided by (Used in) Investing Activities ($81.5m) ($9.6m) ($33.7m) ($14.3m) ($63.9m) ($65.9m) ($6.0m) ($17.6m) ($236.7m) ($33.9m)
Cash flows from financing activities:
Proceeds from Issuance of Common Stock $10.8m $2.5m $2.9m $2.3m $1.8m $3.4m $2.1m $313k $14.3m $14.2m
Payments for Repurchase of Common Stock $8.2m $867k $872k $53k $836k $9.9m $2.5m $13.5m $14.7m
Payments of Ordinary Dividends, Common Stock $25.8m $28.2m $29.8m $31.2m $31.9m $32.0m $34.6m $35.6m $37.0m $38.7m
Proceeds from Noncontrolling Interests $1.2m $0
Proceeds from (Payments to) Noncontrolling Interests $2.5m ($964k) $250k $0 $1.1m $150k
Dividends Payable, Current $6.8m $7.3m $7.6m $8.0m $8.0m $8.5m $8.7m $9.1m $9.4m $9.9m
Net Cash Provided by (Used in) Financing Activities ($27.1m) ($49.1m) ($77.3m) ($79.7m) ($41.9m) ($35.3m) ($47.6m) ($42.5m) $100.3m ($136.0m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($17.7m) $35.8m ($12.5m) $6.1m $97.5m ($38.8m) ($44.9m) $51.1m ($29.0m) $15.3m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($17.7m) $67.4m $54.9m $61.0m $158.5m $119.7m $74.9m $126.0m $96.9m $112.2m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $5.2m $4.9m $3.1m $1.4m $845k $493k $290k $3.4m $7.0m
Income Taxes Paid, Net $27.7m $23.6m $9.2m $20.9m $16.5m $22.9m $8.8m $14.6m $17.5m $24.7m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.